5 terminated. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 5 |
| Phase 2 | 2 | Terminated 2 |
Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors Felmetatug Vedotin, Pembrolizumab - Ovarian Neoplasms, Peritoneal Neoplasms | Phase 1 | Terminated | Seagen, a wholly owned subsidiary of Pfizer | 250 | 2022-01-12 | 2026-01-09 |
| SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries. Stryker1688 Fluorescence imaging system - Cholecystitis | Phase 1 | Terminated | Stryker Endoscopy | 50 | 2021-06-28 | 2022-09-19 |
| Gemcitabine and Cisplatin With or Without CPI-613 as First Line Therapy for Patients With Advanced Unresectable Biliary Tract Cancer (BilT-04) CPI 613, Gemcitabine, Cisplatin - Biliary Tract Cancer | Phase 1 / Phase 2 | Terminated | University of Michigan Rogel Cancer Center | 75 | 2020-06-23 | 2025-12-31 |
| GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers GL-ONC1 - Solid Organ Cancers | Phase 1 | Terminated | Andrew Lowy | 5 | 2016-03-25 | 2024-08-06 |
| A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer Gemcitabine, Oxaliplatin, Sorafenib - Cholangiocarcinoma, Biliary Tract Cancer | Phase 1 / Phase 2 | Terminated | University of Miami | 9 | 2009-08-01 | 2018-01-03 |
Cholangiocarcinoma (4) · Gallbladder Neoplasms (4) · Biliary Tract Neoplasms (2) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholecystitis (1) · Colorectal Neoplasms (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1) · Melanoma (1) · Mesothelioma (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Peritoneal Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Biliary Tract Diseases (5) · Digestive System Diseases (5) · Adenocarcinoma (4) · Carcinoma (4) · Digestive System Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Neoplasms (3) · Biliary Tract Neoplasms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Abdominal Neoplasms (1) · Adenoma (1)
Gemcitabine (2) · Cisplatin (1) · Oxaliplatin (1) · Sorafenib (1) · devimistat (1) · pembrolizumab (1)
Andrew Lowy (1) · Seagen, a wholly owned subsidiary of Pfizer (1) · Stryker Endoscopy (1) · University of Miami (1) · University of Michigan Rogel Cancer Center (1)
United States (5) · Canada (1) · Germany (1) · Spain (1) · United Kingdom (1)
Kaitlyn Kelly, MD (1) · Peter Hosein, MD (1) · Vaibhav Sahai, MBBS, MS (1)
2023 (1)